STP2 & GAPDH: Partners in crime towards -Synuclein Toxicity

Slides:



Advertisements
Similar presentations
Detection of α-Synuclein in human plasma and its interaction with different apolipoproteins By Fatemeh Nouri Emamzadeh (supervisor David Allsop) Division.
Advertisements

Jessica Price Advanced Cell and Molecular Biology Lake Forest College
Using Gene Knockout and Transgenic Approaches to Evaluate in vivo Functions of CNS Regeneration Inhibitors: How Important is Nogo ? David Mann Tammy Hibler.
Of neurotoxicity and α-synuclein Richard Wilson Clayton DF & George JM (1999) J Neurosci Res 58, 120–129.
Knowledge and Attitudes Toward Genetic Testing in Parkinson’s Disease Dana Lundberg 2006.
Sara Herrera Advisor: Shubhik K. DebBurman Department of Biology Lake Forest College New  -Synuclein Mutants: How Do They Contribute To Parkinson’s Disease?
Rapid detection of drugs for protein misfolding diseases. Alexey Krasnoslobodtsev, Department of Pharmaceutical Sciences, University of Nebraska Medical.
PHL 437/Pharmacogenomics Fourth Lecture (Parkinson’s disease) By Abdelkader Ashour, Ph.D. Phone:
Parkinson’s Disease Pathology 430/826 The Molecular Basis of Disease Neurological Genetics 9 th March 2015 Dr. John Rossiter
Using A Tyrosine-Kinase inhibitor to regulate JNK pathways and see its effect as a possible treatment for Parksinson’s Disease By: Sobi Abbasi.
Lewy Bodies in PD. Lewy Body Inclusions and the effect of coffee and decaffeinated extracts on Drosophila neuronal cultures.
Corso di Terapia genica Prof.ssa Saggio a.a. 2011/2012 LRRK2-FAMILIAR PARKINSON DISEASE: POSSIBLE APPROACH OF GENE THERAPY Cesario Claudia Giusti Valentina.
PDbase : A database of Parkinson’s Disease-related genes and genetic variation using substantia nigra ESTs Jin Ok Yang Korean BioInformation Center (KOBIC)
Deletion of ZAP1 as a transcriptional factor has minor effects on S. cerevisiae regulatory network in cold shock KARA DISMUKE AND KRISTEN HORSTMANN MAY.
Α-synuclein, Lewy Bodies, Prions, and Parkinson’s Disease Cody McCullough & Sara Homsi BCM 465 April 19 th, 2010.
PARKINSON’S DISEASE By Courtney and Niral. WHAT IS IT?  Parkinson's disease (PD) is chronic and progressive movement disorder, meaning that symptoms.
 Phospholipid bilayer  “Mosaic” of proteins The fluid-mosaic model.
PATHOLOGIC AGGREGATION OF THE BRAIN PROTEIN  -SYNUCLEIN CAUSES CELL DEATH IN PARKINSON AND ALZHEIMER DISEASE, Wenbo Zhou, PhD and Curt R. Freed, MD Division.
Genetic Counselling L.O: to explain the role of a genetic counsellor Starter: What sources of information might a genetic counsellor use when examining.
 Parkinson Disease (PD) is a disorder of the brain that causes a variety of movement problems.
 Parkinson’s Disease (PD) -progressive neurodegenerative disease affecting motor ability -third most common neurologic disorder of older adults.
Mounting Evidence that Endocytosis Regulates  -Synuclein Degradation Jaime Pérez Pineda Advanced Cell Biology Fall 2009.
Memory loss Muscle weakness Loss of voluntary movement Dementia Hallucinations Seizures Jerky body movements Tremors Rigidity Confusion Depression Language.
Α-synuclein transgenic mouse models of Parkinson’s disease Michelle Maurer December 2015.
Pathogenesis and pathology of parkinsonism
Figure 3 Purpose: To further characterize cell-to-cell transmission of α- synuclein using an in vitro coculture model Figure 3(A) Hypothesis: If myc-tagged.
Emma Hahs, Brooke Armistead, Sarah Brown, Sok Kean Khoo Department of Cell and Molecular Biology, College of Liberal Arts and Sciences, Grand Valley State.
“HEALTH IS THE BEST” In the name of God. WHAT IS IT? Parkinson's disease (PD) is a chronic and progressive movement disorder, meaning that symptoms.
Sapana Shinde, Aaron Ripley, Dr. Sok Kean Khoo MicroRNA expression studies in rotenone- induced cellular model for Parkinson’s disease Department of Cell.
Parkinson’s Disease.
Idiopathic Parkinson disease
Ubiquitin Proteasome System in Parkinson's Disease:
(Draw and label a picture of a neurone here)
BISC 220 Lab—Series 2 Protein Transport through the Secretory Pathway
Control of Gene Expression
BIO : Bioinformatics Lab
Advisor: Shubhik K. DebBurman Department of Biology
Tejaswini Katravulapalli BNFO 300
Justin Hayase MSTAR Presentation Guo Lab July 23,2009
Alpha-synuclein in Parkinson's disease
Enhanced DNA damage in IDH1 mutant glioma cells.
Chapter 18: Chromosome A Cell Nucleus 149, aa Cytoplasm
Michael C. Pribula, Andras K. Ponti, and Erin E. Johnson
Parkinson’s Common neurodegenerative disorder ~10-20/1000
Protein Synthesis.
Protein Self-Assembly
Chapter 11.4.
Budding yeast has a small genome of approximately 6000 genes.
Inhibition of alpha-synuclein using promazine derivatives
BPTF role in PI3K-AKT pathway in breast cancer
Understanding the structure of a protein involved in Parkinson’s disease -My research proposal was “Relating the structure of aggregated alpha synuclein.
Parkinson’s Diseased Proteins in Relation to Autophagy
Cold Adaptation in Budding Yeast
breast cancer 2, early onset What does this protein make up or do?
Understanding the structure of a protein involved in Parkinson’s disease -My research proposal was “Relating the structure of aggregated alpha synuclein.
David Mann Tammy Hibler Isaac Holmes Arun George Paul
The Role of Astrocyte Dysfunction in Parkinson’s Disease Pathogenesis
BPTF role in PI3K-AKT pathway in breast cancer
Volume 4, Issue 2, Pages e4 (February 2017)
Relationship between Genotype and Phenotype
Tai LT, Daran-Lapujade P, Walsh MC, Pronk JT, Daran JM
Gene expression and regulation & Mutations
Justin Hayase MSTAR Presentation Guo Lab July 23,2009
Parkinson's Disease Neuron
Cell Communication (Signaling) Part 3
Mechanisms Underlying Inflammation in Neurodegeneration
Cell Communication (Signaling) Part 3
SlMYB21 Encodes an Active Transcription Factor That Interacts With SlJAZ9 and Complements the Arabidopsis Mutant myb21-5. SlMYB21 Encodes an Active Transcription.
Neurodegenerative disease models
Volume 85, Issue 1, Pages (January 2015)
Presentation transcript:

STP2 & GAPDH: Partners in crime towards -Synuclein Toxicity By, Arun George Paul BIO 324

Acknowledgements Dr. Shubhik K. DebBurman Ruja Shrestha Isaac Holmes Chris Prater Tulaza Vaidya Sara Herrera Katrina Brandies Jessica Price Saccharomyces cerevisiae

The Big Picture: Parkinson Disease (PD) Affects 4 million people world wide A Progressive Neurodegerative Disorder Major symptoms: - Tremor at rest - Slowness of movement - Reduced facial expressions - Balance problems

Pathology of PD Diseased Healthy Death of Dopaminergic Neurons Lewy Bodies Substantia nigra Perves, Augustine, Fitzpatrick et al.Neuroscience, 2nd edition Spillantini, Schmidt, Lee et al -Synuclein in lewy bodies. Nature 1997.

? Molecular Theme of PD Lewy Bodies Aggregated -Synuclein -Synuclein Mutant -Synuclein A30P A53T Over expression of -Synuclein Aggregates

What is -Synuclein ? Proteins Linked to Misfolding What we know? Membrane Binding Protein Proposed to be a dopamine transport protein What we do not know? Why misfolded in dopaminergic neurons Proteins Linked to Misfolding

The Willingham Study My Goal: How? Mildly Toxic Over expression of -Synuclein Mildly Toxic My Goal: How? One Among 86 Genetic Deletions… I selected STP2 Willingham, Stephen, Tiago Fleming Outerio, Michael J. Devit, Susan L. Lindquist, and Paul Muchowski. 2003. Yeast Genes that Enhance the Toxicity of a Mutant Huntingtin Fragment or -synuclein. Science, 302, 1769.

Why STP2? Among 86… Only STP2 Enhanced Toxicity in Both Cases Over expression of -Synuclein & Huntingtin Mildly Toxic Among 86… Only STP2 Enhanced Toxicity in Both Cases

What is STP2? STP2 is required for amino acid intake Nucleus de Boer M, Nielsen PS, Bebelman JP, Heerikhuizen H, Andersen HA, and Planta RJ. Stp1P, Stp2P, and Abfip are involved in regulation of expression of the amino acid transporter gene BAP3 of Saccharomyces cerevisiae. Nucleic Acids Res., 28, 974.

How is STP2 & -Synuclein Toxicity Linked ? STP2 deletion increases GAPDH Levels Nucleus GAPDH Increased STP2 Eckert-Boulet N, Nielsen PS, Friis C, dos Santos MM, Nielsen J, Kielland-Brandt MC, and Regenberg B. 2004. Transcriptional profiling of extracellular amino acid sensing in Saccharomyces cerevisiae and the role of stp2 and stp2. Yeast, 21, 635.

How is GAPDH important? GAPDH is a glycolytic protein GAPDH deletion rescues PD neurons GAPDH is localized with -Synuclein in Lewy Bodies GAPDH3/Hsp35 is a heat shock protein

How is STP2 & -Synuclein Toxicity Linked ? My Hypothesis: Over expression of -Synuclein Mildly Toxic More Cell Death STP2 Enhanced by STP2 Deletion GAPDH Increased

How do I test my hypothesis? Aim 1: ? Mildly Toxic Over expression of -Synuclein Enhanced by STP2 Deletion

How do I test my hypothesis? Aim 2: ? Over expression of -Synuclein By STP2 Deletion -Synuclein Aggregates

How do I test my hypothesis? Aim 3: ? STP2 GAPDH Increased

How do I test my hypothesis? Aim 4: Over expression of -Synuclein Cell Death STP2 GAPDH Increased More Cell Death Reduced Cell Death ?

Our Pet… Saccharomyces cerevisiae or Baker’s Yeast WT A30P A53T -Syn -STP2 +STP2 Control: pYES2 +STP2 -STP2 -Syn Over expresses -Synuclein

Testing Aim 1 by Spotting Assay STP2 Prediction 1 Over expression of -Synuclein + pYES2 - + ? Enhanced by STP2 Deletion WT - + A30P - + Mildly Toxic A53T - + A30P/ A53T -

Testing Aim 2: By Immunoblotting Prediction 2 -Synuclein STP2 Deletion + - A53T WT A30P A30P/ Ladder 62 KDa STP2 Model Blot pYES2 >150 kDA

Testing Aim 2: By GFP Microscopy Prediction 2 -Synuclein STP2 Deletion Potential Aggregate -Synuclein’s Membrane Localization

Testing Aim 2: By GFP Microscopy Prediction 2 -Synuclein STP2 Deletion STP2 Deletion and Non-Deletion Showed the Following Phenotypes A30P/ A53T pYES2 WT A30P A53T Peripheral Cytoplasmic Peripheral Cytoplasmic

Testing Aim 2: By GFP Microscopy Prediction 2 -Synuclein STP2 Deletion STP2 Deletion and Non-Deletion Showed the Following Phenotypes WT A53T WT A53T Potential -Synuclein Aggregates

Testing Aim 3: By Immunoblotting Prediction 3 STP2 GAPDH Increased + - A53T WT A30P A30P/ Ladder 43.5 KDa STP2 Model Blot pYES2 43.5 kDA

Testing Aim 4 by Spotting Assay STP2 Prediction 4 + pYES2 GAPDH - + WT ? - + A30P - + Reduced Cell Death A53T - + A30P/ A53T -

My Hypothesis: More Cell Death Mildly Toxic Over expression of -Synuclein Mildly Toxic More Cell Death STP2 Enhanced by STP2 Deletion GAPDH Increased

What did we see? More Cell Death Mildly Toxic Over expression of -Synuclein Mildly Toxic More Cell Death GAPDH Increased STP2

Negative Results are as important as positive results in the pursuit of science

The Act of Troubleshooting: What did we do different? -Syn By Willingham et. al., (2003) p426 -Syn -Syn pYES2 By Us

The Act of Troubleshooting: What did we do different? Misfolded Proteins Protein-Quality Control Systems Misfolded Proteins Protein-Quality Control Systems Protein-Quality Control Systems Misfolded Proteins

The Act of Troubleshooting: What did we do different? Over expression of -Synuclein Aggregates Mildly Toxic Action of Protein-Quality Control Systems! -Syn pYES2 Not Enough -Synuclein?

The Act of Troubleshooting: What did we do different? GAPDH Increased STP2 -Syn By Eckert-Boulet et. al., (2004) -Syn M4054 By Us -Syn 4741

The Act of Troubleshooting: What did we do different? GAPDH Increased STP2 They used a DNA Microarray GAPDH signal might have been a false positive

Our Proposal Non- 4741/pYES2 -Synuclein System Mildly Toxic Enhanced by STP2 Deletion through GAPDH 4741/pYES2 -Synuclein System No Cell Death Over expression of -Synuclein Not Enhanced by STP2 Deletion through GAPDH

Future Research Applying New Techniques for Detecting Toxicity: FUN Racker Assay Testing our hypothesis on Non-4741/pYES2 -Synuclein Systems Investigating the potential aggregates we saw Exploring the link of GAPDH and -Synuclein in yeast

Questions?